Risk Factors for Long-Term Vancomycin-Resistant Enterococci Persistence—A Prospective Longitudinal Study

Vancomycin-resistant enterococci (VRE) are important nosocomial pathogens that require effective infection control measures, representing a challenge for healthcare systems. This study aimed at identifying risk factors associated with prolonged VRE carriage and determining the rate of clearance that allows the discontinuation of contact precautions. During a 2-year study, screening was performed in patients with a history of VRE or at risk of becoming colonized. After bacterial identification and antibiotic susceptibility testing, glycopeptide resistance was confirmed by PCR. Isolates were compared via whole genome sequence-based typing. Risk factors were recorded, and follow-up screening was performed upon readmission, defining patients as long-term carriers if still colonized ≥10 weeks after first detection. Of 1059 patients positive for VRE, carriage status was assessed upon readmission in 463 patients. VRE was cleared in 56.4% of the cases. Risk factors associated with long-term persistence were hospital stays (frequency, length), hemato-oncological disease, systemic treatment with steroids, and use of antibiotics. No specific genotypic clustering was observed in patients with VRE clearance or persistence. VRE clearance is possibly underestimated. The identification of risk factors favoring long-term carriage may contribute to a targeted implementation of infection control measures upon readmission of patients with history of VRE.

[1]  P. Zachariah,et al.  Vancomycin use in surrounding patients during critical illness and risk for persistent colonization with vancomycin-resistant Enterococcus. , 2019, The Journal of hospital infection.

[2]  Ronald N. Jones,et al.  Temporal and Geographic Variation in Antimicrobial Susceptibility and Resistance Patterns of Enterococci: Results From the SENTRY Antimicrobial Surveillance Program, 1997–2016 , 2019, Open forum infectious diseases.

[3]  Kerri A. Thom,et al.  Bacterial burden is associated with increased transmission to health care workers from patients colonized with vancomycin‐resistant Enterococcus , 2019, American journal of infection control.

[4]  P. Zachariah,et al.  The local hospital milieu and healthcare-associated vancomycin-resistant enterococcus acquisition. , 2019, The Journal of hospital infection.

[5]  Krinko,et al.  Hygienemaßnahmen zur Prävention der Infektion durch Enterokokken mit speziellen Antibiotikaresistenzen , 2018, Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz.

[6]  A. Mellmann,et al.  Hospital acquired vancomycin resistant enterococci in surgical intensive care patients – a prospective longitudinal study , 2018, Antimicrobial Resistance & Infection Control.

[7]  D. Elashoff,et al.  Noninfectious Hospital Adverse Events Decline After Elimination of Contact Precautions for MRSA and VRE , 2018, Infection Control & Hospital Epidemiology.

[8]  G. Alangaden,et al.  The Role of Environmental Contamination in the Transmission of Nosocomial Pathogens and Healthcare-Associated Infections , 2018, Current Infectious Disease Reports.

[9]  P. Gastmeier,et al.  Continuous increase of vancomycin resistance in enterococci causing nosocomial infections in Germany − 10 years of surveillance , 2018, Antimicrobial Resistance & Infection Control.

[10]  M. Ouellette,et al.  Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. , 2017, The Lancet. Infectious diseases.

[11]  T. Eckmanns,et al.  Eigenschaften, Häufigkeit und Verbreitung von VancomycinresistentenEnterokokken (VRE) in Deutschland , 2017 .

[12]  P. Gastmeier,et al.  The effect of antibiotic use on prevalence of nosocomial vancomycin-resistant enterococci- an ecologic study , 2017, Antimicrobial Resistance & Infection Control.

[13]  David Baur,et al.  Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis. , 2017, The Lancet. Infectious diseases.

[14]  A. Hendrickx,et al.  Multidrug-Resistant Enterococcal Infections: New Compounds, Novel Antimicrobial Therapies? , 2017, Trends in microbiology.

[15]  H. Rohde,et al.  Screening and contact precautions – A survey on infection control measures for multidrug-resistant bacteria in German university hospitals , 2017, Antimicrobial Resistance & Infection Control.

[16]  E. Larson,et al.  Temporal trends and risk factors for healthcare-associated vancomycin-resistant enterococci in adults. , 2016, The Journal of hospital infection.

[17]  F. Petersen,et al.  Room contamination, patient colonization pressure, and the risk of vancomycin-resistant Enterococcus colonization on a unit dedicated to the treatment of hematologic malignancies and hematopoietic stem cell transplantation. , 2016, American journal of infection control.

[18]  A. Mellmann,et al.  Real-Time Genome Sequencing of Resistant Bacteria Provides Precision Infection Control in an Institutional Setting , 2016, Journal of Clinical Microbiology.

[19]  J. Haldar,et al.  A Vancomycin Derivative with a Pyrophosphate-Binding Group: A Strategy to Combat Vancomycin-Resistant Bacteria. , 2016, Angewandte Chemie.

[20]  N. Ledeboer,et al.  Resistance Mechanisms, Epidemiology, and Approaches to Screening for Vancomycin-Resistant Enterococcus in the Health Care Setting , 2016, Journal of Clinical Microbiology.

[21]  P. Brindley,et al.  Patient Isolation Precautions: Are They Worth It? , 2016, Canadian respiratory journal.

[22]  F. Román,et al.  Horizontal gene transmission of the cfr gene to MRSA and Enterococcus: role of Staphylococcus epidermidis as a reservoir and alternative pathway for the spread of linezolid resistance. , 2016, The Journal of antimicrobial chemotherapy.

[23]  Malbert R. C. Rogers,et al.  Core Genome Multilocus Sequence Typing Scheme for High-Resolution Typing of Enterococcus faecium , 2015, Journal of Clinical Microbiology.

[24]  M. Juhas Horizontal gene transfer in human pathogens , 2015, Critical reviews in microbiology.

[25]  J. Burke,et al.  Frequency, Risk Factors, and Outcomes of Vancomycin-Resistant Enterococcus Colonization and Infection in Patients with Newly Diagnosed Acute Leukemia: Different Patterns in Patients with Acute Myelogenous and Acute Lymphoblastic Leukemia , 2015, Infection Control & Hospital Epidemiology.

[26]  E. Petinaki,et al.  Risk factors for enterococcal infection and colonization by vancomycin-resistant enterococci in critically ill patients , 2014, Infection.

[27]  R. Chemaly,et al.  The role of the healthcare environment in the spread of multidrug-resistant organisms: update on current best practices for containment , 2014, Therapeutic advances in infectious disease.

[28]  C. Ruscher Empfehlungen zur Prävention und Kontrolle von Methicillin-resistenten Staphylococcus aureus-Stämmen (MRSA) in medizinischen und pflegerischen Einrichtungen , 2014, Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz.

[29]  Y. Carmeli,et al.  Infection control and prevention measures to reduce the spread of vancomycin-resistant enterococci in hospitalized patients: a systematic review and meta-analysis. , 2014, The Journal of antimicrobial chemotherapy.

[30]  R. Walensky,et al.  Natural history of colonization with methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE): a systematic review , 2014, BMC Infectious Diseases.

[31]  K. Peck,et al.  Duration of colonization and risk factors for prolonged carriage of vancomycin-resistant enterococci after discharge from the hospital. , 2013, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[32]  Yee-Chun Chen,et al.  Incidence of and Risk Factors for Infection or Colonization of Vancomycin-Resistant Enterococci in Patients in the Intensive Care Unit , 2012, PloS one.

[33]  gramnegativen Stäbchen Hygienemaßnahmen bei Infektionen oder Besiedlung mit multiresistenten gramnegativen Stäbchen , 2012, Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz.

[34]  M. Ott,et al.  Vancomycin-resistant enterococci (VRE) and the role of the healthcare worker. , 2008, Canadian operating room nursing journal.

[35]  F. Baquero,et al.  Global Spread of Vancomycin-resistant Enterococcus faecium from Distinct Nosocomial Genetic Complex , 2005, Emerging infectious diseases.

[36]  Y. Carmeli,et al.  Antecedent Treatment with Different Antibiotic Agents as a Risk Factor for Vancomycin-Resistant Enterococcus , 2002, Emerging infectious diseases.

[37]  G. Eliopoulos,et al.  Prolonged colonization with vancomycin-resistant Enterococcus faecium in long-term care patients and the significance of "clearance". , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[38]  J. Patterson,et al.  Antibiotic utilization: is there an effect on antimicrobial resistance? , 2001, Chest.

[39]  R. Wiesner,et al.  Natural history of vancomycin‐resistant enterococcal colonization in liver and kidney transplant recipients , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[40]  A. Ambergen,et al.  The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable. , 1998, Archives of internal medicine.

[41]  J. Duval,et al.  Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. , 1988, The New England journal of medicine.

[42]  N. Woodford,et al.  VANCOMYCIN-RESISTANT ENTEROCOCCI , 1988, The Lancet.

[43]  L. Rice,et al.  Vancomycin-resistant enterococci colonization among dialysis patients: a meta-analysis of prevalence, risk factors, and significance. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[44]  W. Schaffner,et al.  MAJOR ARTICLE: Vancomycin‐Resistant Enterococci among Chronic Hemodialysis Patients: A Prospective Study of Acquisition , 2001 .

[45]  D. Fleming,et al.  Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). , 1995, American journal of infection control.